J Côté

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin et al. · Clinical Pharmacology & Therapeutics · 2008 · 99 citations

High-density Lipoprotein, Healthy Subjects, Biochemistry +15

Influence of inhaled steroids on recovery from occupational asthma after cessation of exposure: an 18-month double-blind crossover study.

Malo Jl, A Cartier, J Côté et al. · American Journal of Respiratory and Critical Care Medicine · 1996 · 80 citations

Asthma, Occupational Lung Diseases, Environmental Lung Diseases +14

Air in the portal vein: sonographic and Doppler manifestations.

M Lafortune, B C Trinh, Peter N. Burns et al. · Radiology · 1991 · 65 citations

Varices, Venous Disease, Hepatology +15

Rofecoxib, a COX-2 inhibitor, does not inhibit human gastric mucosal prostaglandin production

Nicholas J. Wight, Keith Gottesdiener, Nigel Garlick et al. · Gastroenterology · 2001 · 62 citations · Full text

Cox-2 Inhibitor, Gastrointestinal Oncology, Gastrointestinal Pharmacology +6

Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination

Rajesh Krishna, Ferdous Gheyas, Yanhong Liu et al. · Clinical Pharmacology & Therapeutics · 2017 · 55 citations